Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer

Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer

Background: 5-Methylcytidine (m5C) is the most common RNA modification and plays an important role in multiple tumors including cervical cancer (CC). We aimed to develop a novel gene signature by identifying m5C modification subtypes of CC to better predict the prognosis of patients.Methods: We obta...

Full description

Bibliographic Details
Main Authors: Jing Yu, Lei-Lei Liang, Jing Liu, Ting-Ting Liu, Jian Li, Lin Xiu, Jia Zeng, Tian-Tian Wang, Di Wang, Li-Jun Liang, Da-Wei Xie, Ding-Xiong Chen, Ju-Sheng An, Ling-Ying Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Genetics
Subjects:
cervical cancer
m5C modification
signature
prognosis
TCGA
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.733715/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2021.733715/full

Similar Items